Tapewire

Nasdaq · USD

ANIP

ANI PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
4638
SEC CIK
0001023024
Parsed reports
463

Last 12 months

Inside the activity.

0 purchase rows · 48 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202503
Jan 202601
Feb 202605
Mar 2026012
Apr 202601
May 202606
Jun 202604
Jul 202603
Aug 202604
Sep 202604
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 14, 2024 Filed Feb 16, 2024 21:30 UTC
Davis KristaSVP, CHIEF HR OFFICER
GrantCommon Stock 12,079 $0.00 $0.00
Disclosure

SEC source: 0001946439-24-000002 · wk-form4_1708119020.xml · nonDerivative · entry 1

Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,666

F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 21:28 UTC
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
GrantCommon Stock 9,842 $0.00 $0.00
Disclosure

SEC source: 0001938861-24-000006 · wk-form4_1708118895.xml · nonDerivative · entry 2

Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,404

F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 21:28 UTC
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
GrantCommon Stock 14,763 $0.00 $0.00
Disclosure

SEC source: 0001938861-24-000006 · wk-form4_1708118895.xml · nonDerivative · entry 1

Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,562

F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 21:26 UTC GrantCommon Stock 14,316 $0.00 $0.00
Disclosure

SEC source: 0001674236-24-000003 · wk-form4_1708118772.xml · nonDerivative · entry 2

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,629

F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 21:26 UTC GrantCommon Stock 21,474 $0.00 $0.00
Disclosure

SEC source: 0001674236-24-000003 · wk-form4_1708118772.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 177,313

F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024.

Read SEC document
February 13, 2024 Filed Feb 14, 2024 01:05 UTC
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
SaleCommon Stock 250 $56.04 $14,010.00
Disclosure

SEC source: 0001938861-24-000004 · wk-form4_1707872714.xml · nonDerivative · entry 1

Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,799

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023.

Read SEC document
January 23, 2024 Filed Jan 23, 2024 22:32 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 15,000 $56.44 $846,600.00
Disclosure

SEC source: 0001870913-24-000004 · wk-form4_1706049128.xml · nonDerivative · entry 4

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 882,620

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $56.00 to $57.11, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
January 22, 2024 Filed Jan 23, 2024 22:32 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 5,692 $55.95 $318,467.40
Disclosure

SEC source: 0001870913-24-000004 · wk-form4_1706049128.xml · nonDerivative · entry 3

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 897,620

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $55.63 to $56.21, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
January 19, 2024 Filed Jan 23, 2024 22:32 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 4,524 $55.57 $251,398.68
Disclosure

SEC source: 0001870913-24-000004 · wk-form4_1706049128.xml · nonDerivative · entry 2

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 903,312

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $55.03 to $56.00, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
January 18, 2024 Filed Jan 18, 2024 23:20 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 9,784 $55.30 $541,055.20
Disclosure

SEC source: 0001870913-24-000002 · wk-form4_1705619998.xml · nonDerivative · entry 4

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 907,836

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $54.70 to $55.73, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
January 17, 2024 Filed Jan 18, 2024 23:20 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 10,000 $55.11 $551,100.00
Disclosure

SEC source: 0001870913-24-000002 · wk-form4_1705619998.xml · nonDerivative · entry 3

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 917,620

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $54.59 to $55.57, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 23:20 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 5,000 $55.63 $278,150.00
Disclosure

SEC source: 0001870913-24-000002 · wk-form4_1705619998.xml · nonDerivative · entry 2

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 927,620

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $54.99 to $56.71, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
January 12, 2024 Filed Jan 17, 2024 02:09 UTC
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
SaleCommon Stock 250 $56.43 $14,107.50
Disclosure

SEC source: 0001938861-24-000002 · wk-form4_1705457345.xml · nonDerivative · entry 1

Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,049

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023.

Read SEC document
December 19, 2023 Filed Dec 19, 2023 22:44 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 25,000 $52.65 $1,316,250.00
Disclosure

SEC source: 0001870913-23-000020 · wk-form4_1703025852.xml · nonDerivative · entry 4

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 932,620

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.45 to $53.19, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
December 18, 2023 Filed Dec 19, 2023 22:44 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 13,026 $52.44 $683,083.44
Disclosure

SEC source: 0001870913-23-000020 · wk-form4_1703025852.xml · nonDerivative · entry 3

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 957,620

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.02 to $52.97, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 22:44 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 11,974 $52.44 $627,916.56
Disclosure

SEC source: 0001870913-23-000020 · wk-form4_1703025852.xml · nonDerivative · entry 2

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 970,646

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.97 to $52.97, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
December 11, 2023 Filed Dec 11, 2023 22:49 UTC
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
SaleCommon Stock 250 $49.21 $12,302.50
Disclosure

SEC source: 0001938861-23-000008 · wk-form4_1702334937.xml · nonDerivative · entry 1

Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,299

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023.

Read SEC document
November 17, 2023 Filed Nov 21, 2023 02:05 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 13,000 $51.00 $663,000.00
Disclosure

SEC source: 0001870913-23-000018 · wk-form4_1700532348.xml · nonDerivative · entry 2

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 982,620

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.70 to $51.43, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
November 16, 2023 Filed Nov 16, 2023 23:11 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 6,448 $51.66 $333,103.68
Disclosure

SEC source: 0001870913-23-000013 · wk-form4_1700176267.xml · nonDerivative · entry 4

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 996,430

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.14 to $52.70, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
November 16, 2023 Filed Nov 21, 2023 01:58 UTC Amendment
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 6,448 $51.66 $333,103.68
Disclosure

SEC source: 0001870913-23-000016 · wk-form4a_1700531880.xml · nonDerivative · entry 3

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 995,620

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.14 to $52.70, inclusive

F3 · ownership.nature: The Reporting Person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
November 15, 2023 Filed Nov 16, 2023 23:13 UTC
Davis KristaSVP, CHIEF HR OFFICER
SaleCommon Stock 2,622 $53.81 $141,089.82
Disclosure

SEC source: 0001946439-23-000005 · wk-form4_1700176406.xml · nonDerivative · entry 1

Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,587

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $53.80 to $53.91, inclusive.

Read SEC document
November 15, 2023 Filed Nov 16, 2023 23:11 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 7,647 $53.64 $410,185.08
Disclosure

SEC source: 0001870913-23-000013 · wk-form4_1700176267.xml · nonDerivative · entry 3

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 1,002,878

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.96 to $54.24, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
November 15, 2023 Filed Nov 21, 2023 01:58 UTC Amendment
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 7,647 $53.64 $410,185.08
Disclosure

SEC source: 0001870913-23-000016 · wk-form4a_1700531880.xml · nonDerivative · entry 2

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 1,002,068

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.96 to $54.24, inclusive.

F3 · ownership.nature: The Reporting Person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
November 14, 2023 Filed Nov 16, 2023 23:11 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 22,095 $53.17 $1,174,791.15
Disclosure

SEC source: 0001870913-23-000013 · wk-form4_1700176267.xml · nonDerivative · entry 2

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 1,010,525

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.95 to $54.07, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
November 14, 2023 Filed Nov 21, 2023 01:58 UTC Amendment
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 22,905 $53.17 $1,217,858.85
Disclosure

SEC source: 0001870913-23-000016 · wk-form4a_1700531880.xml · nonDerivative · entry 1

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 1,009,715

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.95 to $54.07, inclusive.

F3 · ownership.nature: The Reporting Person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
November 13, 2023 Filed Nov 14, 2023 22:04 UTC
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
SaleCommon Stock 250 $52.03 $13,007.50
Disclosure

SEC source: 0001938861-23-000006 · wk-form4_1699999442.xml · nonDerivative · entry 1

Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,549

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023.

Read SEC document
November 10, 2023 Filed Nov 13, 2023 21:02 UTC
Mutz ChristopherHEAD OF RARE DISEASE
SaleCommon Stock 3,000 $52.47 $157,410.00
Disclosure

SEC source: 0001846487-23-000003 · wk-form4_1699909333.xml · nonDerivative · entry 1

Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,607

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.41 to $52.58, inclusive.

Read SEC document
October 19, 2023 Filed Oct 19, 2023 20:28 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 10,000 $57.06 $570,600.00
Disclosure

SEC source: 0001870913-23-000011 · wk-form4_1697747306.xml · nonDerivative · entry 4

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 1,032,620

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $56.50 to $57.69, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
October 18, 2023 Filed Oct 19, 2023 20:28 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 6,242 $57.78 $360,662.76
Disclosure

SEC source: 0001870913-23-000011 · wk-form4_1697747306.xml · nonDerivative · entry 3

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 1,042,620

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $57.15 to $58.41, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
October 17, 2023 Filed Oct 19, 2023 20:28 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 8,758 $58.53 $512,605.74
Disclosure

SEC source: 0001870913-23-000011 · wk-form4_1697747306.xml · nonDerivative · entry 2

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 1,048,862

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $58.03 to $59.47, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
October 16, 2023 Filed Oct 17, 2023 20:32 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 13,063 $58.31 $761,703.53
Disclosure

SEC source: 0001870913-23-000009 · wk-form4_1697574720.xml · nonDerivative · entry 3

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 1,057,620

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $57.75 to $58.88, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
October 13, 2023 Filed Oct 17, 2023 20:32 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 11,937 $57.58 $687,332.46
Disclosure

SEC source: 0001870913-23-000009 · wk-form4_1697574720.xml · nonDerivative · entry 2

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 1,070,683

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $57.36 to $58.00, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
October 02, 2023 Filed Oct 4, 2023 00:00 UTC
Gassert ChadSVP - CORP. DEV. & STRATEGY
SaleCommon Stock 20,000 $56.48 $1,129,600.00
Disclosure

SEC source: 0001871002-23-000009 · wk-form4_1696377605.xml · nonDerivative · entry 2

Gassert Chad · CIK 0001871002 · SVP - CORP. DEV. & STRATEGY

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Chali Properties LLC

Disclosed balance after: 293,226

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F2 · price: Reflects the weighted average price of sales on October 2, 2023. The shares were sold in multiple transactions at prices ranging from $55.90 to $57.66, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC.

Read SEC document
September 19, 2023 Filed Sep 19, 2023 21:14 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 25,333 $61.23 $1,551,139.59
Disclosure

SEC source: 0001870913-23-000007 · wk-form4_1695158086.xml · nonDerivative · entry 4

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 1,082,620

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $60.63 to $61.69, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
September 18, 2023 Filed Sep 19, 2023 21:14 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 8,425 $61.64 $519,317.00
Disclosure

SEC source: 0001870913-23-000007 · wk-form4_1695158086.xml · nonDerivative · entry 3

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 1,107,953

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $61.23 to $62.94, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
September 15, 2023 Filed Sep 19, 2023 21:14 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 16,242 $62.81 $1,020,160.02
Disclosure

SEC source: 0001870913-23-000007 · wk-form4_1695158086.xml · nonDerivative · entry 2

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 1,116,378

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $62.01 to $63.82, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
September 12, 2023 Filed Sep 14, 2023 12:01 UTC
Davis KristaSVP, CHIEF HR OFFICER
Tax withholdingCommon Stock 1,486 $61.91 $91,998.26
Disclosure

SEC source: 0001946439-23-000003 · wk-form4_1694692910.xml · nonDerivative · entry 1

Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,209

F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,108 shares of restricted stock, the grant of which was previously reported.

Read SEC document
September 08, 2023 Filed Sep 11, 2023 22:23 UTC
Lalwani NikhilDirector · PRESIDENT & CEO
Tax withholdingCommon Stock 3,646 $61.94 $225,833.24
Disclosure

SEC source: 0001822629-23-000004 · wk-form4_1694471020.xml · nonDerivative · entry 1

Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 349,744

F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 7,127 shares of restricted stock, the grant of which was previously reported.

Read SEC document
September 01, 2023 Filed Sep 5, 2023 21:06 UTC
Gassert ChadSVP - CORP. DEV. & STRATEGY
SaleCommon Stock 20,000 $64.70 $1,294,000.00
Disclosure

SEC source: 0001871002-23-000006 · wk-form4_1693947949.xml · nonDerivative · entry 2

Gassert Chad · CIK 0001871002 · SVP - CORP. DEV. & STRATEGY

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Chali Properties LLC

Disclosed balance after: 313,226

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

F2 · price: Reflects the weighted average price of sales on September 1, 2023. The shares were sold in multiple transactions at prices ranging from $64.18 to $65.26, inclusive.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC.

Read SEC document
August 29, 2023 Filed Aug 30, 2023 20:29 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 25,000 $63.37 $1,584,250.00
Disclosure

SEC source: 0001870913-23-000005 · wk-form4_1693427333.xml · nonDerivative · entry 3

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 1,132,620

F3 · price: Reflects the weighted average price of sales on August 29, 2023. The shares were sold in multiple transactions at prices ranging from $62.4877 to $63.92, inclusive.

F2 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
August 28, 2023 Filed Aug 30, 2023 20:29 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 25,000 $63.06 $1,576,500.00
Disclosure

SEC source: 0001870913-23-000005 · wk-form4_1693427333.xml · nonDerivative · entry 2

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 1,157,620

F1 · price: Reflects the weighted average price of sales on August 28, 2023. The shares were sold in multiple transactions at prices ranging from $62.57 to $64.64, inclusive.

F2 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 20:22 UTC
Gutwerg OriSVP, GENERICS
Exercise / conversionStock Option (right to buy) · Derivative 13,502 $31.49 Strike: $31.49 $425,177.98
Disclosure

SEC source: 0001846478-23-000002 · wk-form4_1692994951.xml · derivative · entry 4

Gutwerg Ori · CIK 0001846478 · SVP, GENERICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,504

Underlying: Common Stock · 13,502 shares

Expires 2031-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 25% of the total options vested on each of February 15, 2022 and February 15, 2023. 25% of the total options will vest on each of February 15, 2024 and February 15, 2025.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 20:22 UTC
Gutwerg OriSVP, GENERICS
SaleCommon Stock 2,059 $62.39 $128,461.01
Disclosure

SEC source: 0001846478-23-000002 · wk-form4_1692994951.xml · nonDerivative · entry 3

Gutwerg Ori · CIK 0001846478 · SVP, GENERICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,915

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $62.32 to $62.50, inclusive.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 20:22 UTC
Gutwerg OriSVP, GENERICS
SaleCommon Stock 13,502 $62.39 $842,389.78
Disclosure

SEC source: 0001846478-23-000002 · wk-form4_1692994951.xml · nonDerivative · entry 2

Gutwerg Ori · CIK 0001846478 · SVP, GENERICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,974

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $62.31 to $62.68, inclusive.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 20:22 UTC
Gutwerg OriSVP, GENERICS
Exercise / conversionCommon Stock 13,502 $31.49 $425,177.98
Disclosure

SEC source: 0001846478-23-000002 · wk-form4_1692994951.xml · nonDerivative · entry 1

Gutwerg Ori · CIK 0001846478 · SVP, GENERICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,476

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 20:17 UTC
Marken James G.SVP OPS & PROD DEV
Exercise / conversionStock Option (right to buy) · Derivative 1,667 $33.00 Strike: $33.00 $55,011.00
Disclosure

SEC source: 0001579587-23-000005 · wk-form4_1692994664.xml · derivative · entry 5

Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,667 shares

Expires 2024-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 25% of the total options vested on each of April 1, 2015, April 1, 2016, April 1, 2017, and April 1, 2018.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 20:17 UTC
Marken James G.SVP OPS & PROD DEV
Exercise / conversionStock Option (right to buy) · Derivative 3,750 $40.59 Strike: $40.59 $152,212.50
Disclosure

SEC source: 0001579587-23-000005 · wk-form4_1692994664.xml · derivative · entry 4

Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,750 shares

Expires 2026-04-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 25% of the total options vested on each of April 7, 2017, April 7, 2018, April 7, 2019, and April 7, 2020.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 20:17 UTC
Marken James G.SVP OPS & PROD DEV
SaleCommon Stock 3,932 $63.00 $247,716.00
Disclosure

SEC source: 0001579587-23-000005 · wk-form4_1692994664.xml · nonDerivative · entry 3

Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,112

Read SEC document
August 23, 2023 Filed Aug 25, 2023 20:17 UTC
Marken James G.SVP OPS & PROD DEV
Exercise / conversionCommon Stock 1,667 $33.00 $55,011.00
Disclosure

SEC source: 0001579587-23-000005 · wk-form4_1692994664.xml · nonDerivative · entry 2

Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,044

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 20:17 UTC
Marken James G.SVP OPS & PROD DEV
Exercise / conversionCommon Stock 3,750 $40.59 $152,212.50
Disclosure

SEC source: 0001579587-23-000005 · wk-form4_1692994664.xml · nonDerivative · entry 1

Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,377

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.